Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
Most patients begin noticing a decrease in appetite and improved control over cravings within the first one to two weeks of starting GLP-1 treatment
This is to be expected
Metabolic reprogramming: a bridge between aging and tumorigenesis
Pickart L, Thaler MM
Here's the definitive quick reference: SIGNATURE TOXICITIES & ANTIDOTES: Cyclophosphamide = Hemorrhagic Cystitis MESNA (2-Mercaptoethane Sulfonate) Methotrexate = Myelosuppression Leucovorin (Folinic Acid) Rescue Doxorubicin = Cardiotoxicity Dexrazoxane (Cardioprotective) Cisplatin = Nephrotoxicity, Ototoxicity Amifostine (Cytoprotective) Bleomycin = Pulmonary Fibrosis (No antidote Prevention) Vincristine = Peripheral Neuropathy (No antidote Dose limiting) 5-FU = Palmar-Plantar Erythrodysesthesia (Hand-Foot Syndrome) CLASSIFICATION: Cell Cycle Specific: MTX (S), 5-FU (S), Vinca alkaloids (M), Taxanes (M) Cell Cycle Non-Specific: Cyclophosphamide, Doxorubicin, Cisplatin Mnemonic: "MESNA = Makes Cyclophosphamide Safe (NA)" One topic
US$ 27.49
US$ 21.09
US$ 20.39
US$ 20.08
US$ 27.32
